APA (7th ed.) Citation

Klotz, L., Berger, T., Brownlee, W. J., Chan, A., Lycke, J., Oreja-Guevara, C., . . . Giovannoni, G. (2025). Twenty years of natalizumab in multiple sclerosis: Lessons learned and future outlook. Therapeutic advances in neurological disorders, 18, 17562864251372752. https://doi.org/10.1177/17562864251372752

Chicago Style (17th ed.) Citation

Klotz, Luisa, et al. "Twenty Years of Natalizumab in Multiple Sclerosis: Lessons Learned and Future Outlook." Therapeutic Advances in Neurological Disorders 18 (2025): 17562864251372752. https://doi.org/10.1177/17562864251372752.

MLA (9th ed.) Citation

Klotz, Luisa, et al. "Twenty Years of Natalizumab in Multiple Sclerosis: Lessons Learned and Future Outlook." Therapeutic Advances in Neurological Disorders, vol. 18, 2025, p. 17562864251372752, https://doi.org/10.1177/17562864251372752.